**Core Concept**
The site of action of loop diuretics like furosemide involves the inhibition of the sodium-potassium-chloride cotransporter (NKCC2) in the thick ascending limb of the loop of Henle. This results in increased sodium and chloride excretion, leading to diuresis and natriuresis.

**Why the Correct Answer is Right**
Furosemide binds to the NKCC2 transporter in the luminal membrane of the thick ascending limb cells, preventing the reabsorption of sodium, potassium, and chloride ions. This action increases the amount of these ions in the lumen, leading to their excretion in the urine. The inhibition of NKCC2 also leads to a decrease in the reabsorption of calcium ions, which can contribute to the hypocalcemia seen with loop diuretics.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the site of action of thiazide diuretics is the distal convoluted tubule, not the thick ascending limb of the loop of Henle.

**Option B:** This option is incorrect because the site of action of potassium-sparing diuretics like spironolactone is the collecting duct, not the thick ascending limb of the loop of Henle.

**Option D:** This option is incorrect because the site of action of carbonic anhydrase inhibitors like acetazolamide is the proximal convoluted tubule, not the thick ascending limb of the loop of Henle.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that loop diuretics like furosemide can cause hypokalemia, hypomagnesemia, and hypocalcemia due to their mechanism of action, which involves the inhibition of sodium, potassium, and chloride reabsorption in the thick ascending limb of the loop of Henle.

**Correct Answer: C. Thick ascending limb of the loop of Henle.**